James Barresi, who heads the firm's financial services practice, explains how his time as an in-house lawyer at US Bancorp in the 1990s has shaped his approach to private practice and how he works with clients considering a deal.
M&A lawyer Krishna Veeraraghavan talked about healthcare dealmaking and the risks of excessive antitrust regulation of combinations between biotech and pharma companies in the Drinks With The Deal podcast.
With ESG now a day-to-day focus for management and directors across industries, companies would be well-served to undertake a thoughtful assessment of ESG risks when evaluating potential targets in M&A activities.
The Mintz partner discusses his transition from peace negotiator to M&A lawyer, why he enjoys the middle market, what he's learned from advising reps and warranties insurers and how he finds serenity on sailboats in the latest edition of Drinks With The Deal.
Rob Jackson, a former SEC commissioner and current NYU Law professor, and John Morley, a professor at Yale Law School, say SPACs should be treated more stringently by the SEC and discuss their current research projects.
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.